Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
about
Genomic alterations and molecular subtypes of gastric cancers in AsiansNoncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and BiomarkersPD-L1 is an independent prognostic predictor in gastric cancer of Western patients.Immunotherapy for Gastroesophageal CancerEpstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutationsClinical impact of tumour biology in the management of gastroesophageal cancerSomatic copy number alterations in gastric adenocarcinomas among Asian and Western patients.Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies.Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.Ramucirumab for the treatment of gastroesophageal cancers.Protein profiling of alpha-fetoprotein producing gastric adenocarcinoma.Perioperative transfusion of leukocyte depleted blood products in gastric cancer patients negatively influences oncologic outcome: A retrospective propensity score weighted analysis on 610 curatively resected gastric cancer patients.Pathogenesis of Gastric Cancer.PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidenceCurrent status of ramucirumab in gastroesophageal adenocarcinoma.Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathwaysNew agents on the horizon in gastric cancer.Chemotherapy for advanced gastric cancer: future perspective in Japan.Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.Molecular classification of gastric cancer.Molecular subtypes in cancers of the gastrointestinal tract.Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer.SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors.Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity.Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers.Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.[Novel pharmaceutical treatment approaches for gastric cancer].A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer.Emerging Therapies in the Management of Advanced-Stage Gastric CancerWhat's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future PerspectivesPrognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancerComputational measurement of tumor immune microenvironment in gastric adenocarcinomasPrognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis
P2860
Q26751062-20B0E3FC-2786-4ABD-9440-640D6A2D62D9Q26785700-F3ABD140-CDB7-46F5-8ABC-7D57BDB0E58FQ27853364-A978C764-A78B-4269-8FCB-DD3C93AD0ADAQ28069873-1DA553EA-8DED-46FA-AA62-E607EBE5091BQ33608197-1BC89371-45FB-46D3-BEDE-187278E1C889Q33922534-27B1A627-B410-485B-B791-61CF08FEABABQ36352133-FED97ED0-F9BD-4EFF-9F72-089FBE12D3C9Q36358014-EA8A8743-AE54-4AF3-B60B-77C7006E9034Q37012537-9B3D4F99-5387-4651-B388-CB33B70D87D5Q37050045-767BE4A3-C0FC-4BBF-9C5F-4B159BC6B3F8Q37174690-CF403FCA-C61C-45A5-BE2E-C6C779E10EDAQ37211153-C45AAC13-EC65-4639-9669-64424DBCB4E7Q37317578-68D4833E-3089-4ADC-8506-BCD64E180ADCQ37605526-FA648468-F866-4B05-86E7-D5C0E1F42CF8Q38587346-54535887-D780-456D-B7A9-B1EC783C0D5CQ38649562-D2FFA557-B5D9-46BA-92E4-2460E6BE62CDQ38691733-2CAE6513-6462-4651-A948-3F2949A713EFQ38741017-C6F01104-BB8A-41DC-B109-A0D290396746Q38759129-3CC5B12D-D8C4-407F-BF43-13E66DF7BCBDQ38815071-ADFA4EC7-9E24-4F99-9B56-A57E0E1235A2Q39038545-0EA218D1-6C8A-4079-93DD-13A70985ECC6Q39101373-B7883550-FC5B-478E-B505-B2124AB06DEFQ39235977-3A7D2A77-AC88-40A4-A1AE-389C7C89CF37Q40207742-F98FAE1B-C1EA-44D9-8E33-EDCEFFACF34FQ41967898-DDCC9221-A245-4FA4-8831-D4078607FE43Q42682692-E3C43039-5114-416C-A386-0799615DEC9CQ46498642-93FD351B-EBEE-455F-9799-D1E53DEA6E60Q47577423-1934EAEF-39BA-4D26-95E4-C67CCF21A633Q47728785-E43FE248-599B-41B7-AA35-2909EE902319Q48199486-8DE3CC5D-DB72-4D20-AE96-795E59DD92B1Q48569564-E82521DC-B746-4867-A74D-0151C896F95DQ52643527-C6C07398-FFF4-4799-B04B-06D23A148608Q52802735-B51E87BA-8C0E-4160-9E12-85C8EB19A12FQ53750080-0A0B1705-D752-41B5-8269-7142BF770C3EQ55227468-A77F4464-7ACC-4A4C-A097-F176D96917E3Q57111080-ACA12776-6E47-44FB-AC29-96BFC1335670Q57159608-AFEE2892-7CBD-4413-A52C-6FA94AA5B49BQ57167306-61686BEA-387C-47D1-99AE-580B6EAD9ADDQ58734129-2D91E676-E22F-48A6-90AA-C4C136C5305CQ58789034-6702256B-B06F-4359-B4F8-B39BC2B0EE8B
P2860
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@ast
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@en
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@en-gb
type
label
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@ast
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@en
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@en-gb
prefLabel
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@ast
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@en
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.
@en-gb
P2093
P2860
P50
P953
P6366
P1154
2-s2.0-84947942506
P1433
P1476
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
@en
P2093
Akira Tsuburaya
Axel Zur Hausen
Heike I Grabsch
Hyun Cheol Chung
Iain Beehuat Tan
Jae Ho Cheong
Jeeyun Lee
Johann A Gagnon-Bartsch
Ju-Seog Lee
Khay Guan Yeoh
P2860
P304
P356
10.1136/GUTJNL-2014-308252
P407
P5530
P577
2014-11-10T00:00:00Z
P5875
P6179
1012107927
P6366
2150024391